KRAS and breast carcinoma: KRAS signaling and MYC targets v1 gene sets were de-emphasized in the BRCA + OV + UCEC model, pointing to a less prominent role of these pathways in determining breast cancer disease progression (See Fig. 5D and Tables S5 and S6).